acebutolol has been researched along with Anterior Choroidal Artery Infarction in 1 studies
Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T | 1 |
| Matsubara, T | 1 |
| Nagai, Y | 1 |
| Funauchi, M | 1 |
| Fujimoto, T | 1 |
| Saito, T | 1 |
| Tone, K | 1 |
| Sakoda, S | 1 |
1 trial available for acebutolol and Anterior Choroidal Artery Infarction
| Article | Year |
|---|---|
Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction.
Topics: Acebutolol; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Ca | 1997 |